United States

People: Johnson & Johnson (JNJ)

JNJ on New York Consolidated

25 Oct 2016
Change (% chg)

$0.35 (+0.31%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Gorsky, Alex 

Mr. Alex Gorsky is the Chairman, Board of Directors of the company in December 2012. He was named Chief Executive Officer, Chairman of the Executive Committee and joined the Board of Directors in April 2012. Mr. Gorsky began his Johnson & Johnson career with Janssen Pharmaceutica Inc. in 1988. Over the next 15 years, he advanced through positions of increasing responsibility in sales, marketing, and management. In 2001, Mr. Gorsky was appointed President of Janssen Pharmaceutical Inc., and in 2003 he was named Company Group Chairman of the Johnson & Johnson pharmaceutical business in Europe, the Middle East and Africa. Mr. Gorsky left Johnson & Johnson in 2004 to join the Novartis Pharmaceuticals Corporation, where he served as head of the company’s pharmaceutical business in North America. Mr. Gorsky returned to Johnson & Johnson in 2008 as Company Group Chairman for Ethicon. In early 2009, he was appointed Worldwide Chairman of the Surgical Care Group and member of the Executive Committee. In September 2009, he was appointed Worldwide Chairman of the Medical Devices and Diagnostics Group. Mr. Gorsky became Vice Chairman of the Executive Committee in January 2011. Mr. Gorsky also serves on the boards of the Travis Manion Foundation, the Congressional Medal of Honor Foundation and the National Academy Foundation.

Basic Compensation

Total Annual Compensation, USD 5,623,000
Restricted Stock Awards, USD 10,693,400
Long-Term Incentive Plans, USD --
All Other, USD 7,479,440
Fiscal Year Total, USD 23,795,900

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Alex Gorsky


Dominic Caruso


Sandra Peterson


Paulus Stoffels


Michael Ullmann


Peter Fasolo

As Of  2 Jan 2016